intended audience

This activity was developed for physicians and other health care providers within the Veterans Healthcare System who have an interest in the diagnosis and management of patients with chronic ITP.

learning objectives

Upon completion of this activity, participants should be better able to:

Appropriately and rapidly diagnose ITP in their patients

Provide treatment utilizing current guidelines and best evidence-based treatment protocols

Incorporate evolving treatment options into their practice to provide optimal treatment for their patients

additional pharmacy learning objectives

Upon completion of this activity, participants should be better able to:

Incorporate data on existing and emerging treatment options for ITP to be able to provide optimal consulting input in the VA health system

additional nursing learning objectives

Upon completion of this activity, participants should be better able to:

Utilize an understanding of the disease process and options to better provide optimal care and counseling services to patients with ITP

This activity will address professional practice gaps in knowledge and competence.

accreditation and certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credittm. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #797-000-09-011-H04-P. This program is designated for up to 1 contact hour (0.1 CEUs) of continuing pharmacy education credit.

Annenberg Center for Health Sciences is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

This program is accredited for 1 contact hour which includes 0.25 hour of pharmacology. Program ID #4654.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1 contact hour may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be mailed 4-6 weeks following activity participation, upon submission of the evaluation form.

disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

Kenneth A. Bauer, MD	Consultant:	Bayer Healthcare Johnson & Johnson
	Speakers Bureau:	GlaxoSmithKline

Michael J. Kelley, MD	Research Support:	Bristol-Myers Squibb Company GlaxoSmithKline Proacta

Craig S. Kitchens, MD	Speakers Bureau:	GlaxoSmithKline

The following faculty have no significant relationship to disclose:
Mark C. Geraci, PharmD, BCOP

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

	Carol Marietta, NP	Nothing to disclose
	Rich Nelson, PharmD	Nothing to disclose
	Anne Greenberg (medical writer)	Nothing to disclose

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from GlaxoSmithKline.

This activity is an enduring material and consists of a web archive. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

This activity was originally released in August 2009 and is eligible for credit through July 31, 2010.

If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Christina Irons by phone: 800-321-3690, by fax: 760-773-4550, or by e-mail: registration@annenberg.net. All requests must be received at least 14 days in advance of the intended activity start date.